Bergen Brunswig Completes Acquisition of PharMerica

Bergen Brunswig Corp. (Orange, CA) has completed its acquisition of PharMerica Inc. (Tampa, FL), one of the nation's largest providers of pharmaceutical products and pharmacy management services to long-term care and alternate site settings. Under the terms of the acquisition, shareowners of PharMerica will receive a fixed exchange ratio of 0.275 of a share of Bergen Brunswig common stock for each share of PharMerica stock they own.

Bergen has also amended its $400 million credit facility to allow a $600 million, 364-day facility, which together will be used to back up a new commercial paper program.

PharMerica Inc. provides its services to patients in skilled nursing facilities, assisted living facilities, residential and independent living communities, specialty hospitals and the home setting.

Bergen Brunswig Corp. is a supply channel management company, providing pharmaceuticals, medical-surgical supplies, and specialty products as well as information management solutions and outsourcing services designed to customers, patients, and manufacturers across the healthcare spectrum.

For more information: Neil F. Dimick, CFO, Bergen Brunswig Corp., 4000 Metropolitan Dr., Orange, CA 92868-3598. Tel: 714-385-4000. Fax: 714-385-1442.